NEU 2.81% $18.65 neuren pharmaceuticals limited

Wilsons target $18.29 and summary, page-65

  1. 1,096 Posts.
    lightbulb Created with Sketch. 478
    Normally I would agree with you. I’ve lost significant gains twice on a company before, finally pulling the plug with a much reduced but respectable profit. A lesson not to stay fully invested emotionally in a stock. But Neuren is all about the runway and enormous growth should their plans come to fruition. I haven’t come across a company like this on the Australian bourses with so much potential. It is an outlier.
    Last edited by Eagle0: 18/05/23
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.